[PDF][PDF] A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
A Tauzin, M Nayrac, M Benlarbi, SY Gong, R Gasser… - Cell host & …, 2021 - cell.com
While the standard regimen of the BNT162b2 mRNA vaccine for SARS-CoV-2 includes two
doses administered 3 weeks apart, some public health authorities are spacing these doses, …
doses administered 3 weeks apart, some public health authorities are spacing these doses, …
[PDF][PDF] Cross-sectional evaluation of humoral responses against SARS-CoV-2 spike
…, A Laumaea, SP Anand, G Goyette, M Benlarbi… - Cell Reports …, 2020 - cell.com
SARS-CoV-2 is responsible for the coronavirus disease 2019 (COVID-19) pandemic, infecting
millions of people and causing hundreds of thousands of deaths. The Spike glycoproteins …
millions of people and causing hundreds of thousands of deaths. The Spike glycoproteins …
[PDF][PDF] Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset
…, M Nayrac, G Beaudoin-Bussières, M Benlarbi… - Cell Reports …, 2021 - cell.com
With the recent approval of highly effective coronavirus disease 2019 (COVID-19) vaccines,
functional and lasting immunity to severe acute respiratory syndrome coronavirus 2 (SARS-…
functional and lasting immunity to severe acute respiratory syndrome coronavirus 2 (SARS-…
[PDF][PDF] Live imaging of SARS-CoV-2 infection in mice reveals that neutralizing antibodies require Fc function for optimal efficacy
…, G Beaudoin-Bussières, K Symmes, M Benlarbi… - Immunity, 2021 - cell.com
Neutralizing antibodies (NAbs) are effective in treating COVID-19, but the mechanism of
immune protection is not fully understood. Here, we applied live bioluminescence imaging (BLI) …
immune protection is not fully understood. Here, we applied live bioluminescence imaging (BLI) …
[PDF][PDF] A Fc-enhanced NTD-binding non-neutralizing antibody delays virus spread and synergizes with a nAb to protect mice from lethal SARS-CoV-2 infection
…, J Prévost, WD Tolbert, K Symmes, S Ding, M Benlarbi… - Cell reports, 2022 - cell.com
Emerging evidence indicates that both neutralizing and Fc-mediated effector functions of
antibodies contribute to protection against SARS-CoV-2. It is unclear whether Fc-effector …
antibodies contribute to protection against SARS-CoV-2. It is unclear whether Fc-effector …
[PDF][PDF] Strong humoral immune responses against SARS-CoV-2 Spike after BNT162b2 mRNA vaccination with a 16-week interval between doses
…, D Vézina, R Gasser, L Nault, L Marchitto, M Benlarbi… - Cell host & …, 2022 - cell.com
The standard regimen of the BNT162b2 mRNA vaccine for SARS-CoV-2 includes two doses
administered three weeks apart. However, some public health authorities spaced these …
administered three weeks apart. However, some public health authorities spaced these …
[PDF][PDF] Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccine
A Tauzin, A Nicolas, S Ding, M Benlarbi, H Medjahed… - Cell Reports, 2023 - cell.com
Several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron subvariants
have recently emerged, becoming the dominant circulating strains in many countries. …
have recently emerged, becoming the dominant circulating strains in many countries. …
[HTML][HTML] Impact of temperature on the affinity of SARS-CoV-2 Spike glycoprotein for host ACE2
…, D Adam, NG Vergara, A Tauzin, M Benlarbi… - Journal of Biological …, 2021 - ASBMB
The seasonal nature of outbreaks of respiratory viral infections with increased transmission
during low temperatures has been well established. Accordingly, temperature has been …
during low temperatures has been well established. Accordingly, temperature has been …
Integrated immunovirological profiling validates plasma SARS-CoV-2 RNA as an early predictor of COVID-19 mortality
…, A Pagliuzza, R Gasser, M Benlarbi… - Science …, 2021 - science.org
Despite advances in COVID-19 management, identifying patients evolving toward death
remains challenging. To identify early predictors of mortality within 60 days of symptom onset (…
remains challenging. To identify early predictors of mortality within 60 days of symptom onset (…
Short-term antibody response after 1 dose of BNT162b2 vaccine in patients receiving hemodialysis
R Goupil, M Benlarbi, W Beaubien-Souligny… - Cmaj, 2021 - Can Med Assoc
BACKGROUND: Patients receiving in-centre hemodialysis are at high risk of exposure to
SARS-CoV-2 and death if infected. One dose of the BNT162b2 SARS-CoV-2 vaccine is …
SARS-CoV-2 and death if infected. One dose of the BNT162b2 SARS-CoV-2 vaccine is …